These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4935137)

  • 1. [Administration of fenfluramine in double blind trial in patients with exogenous obesity. Analysis of therapeutic results and effects on lipid metabolism].
    Toledo SP; Neto GA
    Rev Bras Med; 1971 May; 28(5):240-5. PubMed ID: 4935137
    [No Abstract]   [Full Text] [Related]  

  • 2. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
    Elliott BW
    Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

  • 7. Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.
    Waal-Manning HJ; Simpson FO
    Lancet; 1969 Dec; 2(7635):1392-5. PubMed ID: 4188278
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic and therapeutic effects of EMTP in obesity.
    Hollingsworth DR; Amatruda TT
    Clin Pharmacol Ther; 1969; 10(4):540-2. PubMed ID: 4893585
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenfluramine up to date.
    Drug Ther Bull; 1970 Mar; 8(6):21-3. PubMed ID: 5440616
    [No Abstract]   [Full Text] [Related]  

  • 10. To the Editor: Fenfluramine (Poderax) for obesity.
    Jackson WP
    S Afr Med J; 1969 Sep; 43(39):1207. PubMed ID: 5353789
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 12. A treatment for refractory obesity using fenfluramine without dietary restriction.
    Sedgwick JP
    Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenfluramine, a new anorexigenic agent.
    Hadler AJ
    J Clin Pharmacol New Drugs; 1971; 11(1):52-5. PubMed ID: 4926397
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind clinical trial of an appetite depressant, fenfluramine, in general practice.
    Brodbin P; O'Connor CA
    Practitioner; 1967 May; 198(187):707-10. PubMed ID: 4860039
    [No Abstract]   [Full Text] [Related]  

  • 15. Fenfluramine in obesity.
    S Afr Med J; 1968 Jul; 42(27):682. PubMed ID: 5673819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind clinical trial of fenfluramine.
    Lele RD; Joshi VR; Nathwani AN
    Br J Clin Pract; 1972 Feb; 26(2):79-82. PubMed ID: 4552745
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of fenfluramine--a double-blind study.
    Petrie JC; Mowat JA; Bewsher PD; Stowers JM
    Postgrad Med J; 1975; 51 Suppl 1():139-44. PubMed ID: 768954
    [No Abstract]   [Full Text] [Related]  

  • 19. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fenfluramine. Anorexigenic drug in obstetrical practice].
    Ramírez Soto E; Delgado Urdapilleta J
    Ginecol Obstet Mex; 1969 Apr; 25(150):425-32. PubMed ID: 5814199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.